Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
The Journal of Infectious Diseases|May 23, 2020
Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral TherapyMichael C Sneller, Erin D Huiting, Katherine E Clarridge, et al.
American Journal of Epidemiology|August 21, 2025
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-upEthan Ashby, Holly Janes, Dean Follmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2015
Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral TherapyCaryn G Morse, Mary McLaughlin, Lindsay Matthews, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patientsVeronique Nussenblatt, Mary McLaughlin, Catherine A Rehm, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Richard H. Grimm, Karen L. Margolis, Vasilios Papademetriou, et al.
Open Forum Infectious Diseases|December 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE TrialDean Follmann, Xiaowei Wang, Lindsey R Baden, et al.
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
Nature Communications|October 14, 2025
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19Rhiannon Edge, Sam Matthews, Bahar Ahani, et al.
American Journal of Infection Control|March 3, 2019
Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithmsSameer S Kadri, Jeffrey R Strich, Bruce J Swihart, et al.
Statistics in Medicine|September 11, 2012
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?Michael Proschan, Charles E Ford, Jeffrey A Cutler, et al.
Pageof 19